Clinical UpdatesDrug News

Pharmaceutical companies defended themselves on Tuesday against complaints of rising drug prices that could re-establish the drug industry as a… »   

In Uganda, health experts are getting laboratories ready and preparing villagers in two districts for a large clinical trial to… »   

Countries should phase out the use of Stavudine, the most widespread antiretroviral, because of “long-term, irreversible” side-effects in HIV patients… »   

A Philadelphia jury on Monday ordered Pfizer Inc to pay $28 million in punitive damages to a breast cancer survivor… »   

The Infectious Diseases Society of America (IDSA) has asked for a commitment from the Obama administration and the European Union… »   

The U.S. House of Representatives voted on Thursday to boost Medicare payments to physicians in a move that could help… »   

Senior Democrats in the U.S. House of Representatives are seeking a government investigation into recent price increases of brand-name prescription… »   

Asia will receive a stockpile of 500,000 courses of H1N1 flu drugs by April next year to supplement any shortfall… »   

Drug makers, Internet companies and nonprofits packed a hearing into what is a gray area for U.S. health regulators: how… »   

Three more members of Britain’s drug advisory panel quit on Tuesday, media reported, as a row between scientists and the… »   

A pivotal efficacy trial of RTS,S, the world’s most clinically advanced malaria vaccine candidate, is now underway in seven African… »   

Up to 30 million doses of vaccine against the H1N1 swine flu virus have been delivered to the U.S. government… »   

Nearly a million people die from malaria each year because they cannot afford the most effective treatment and instead often… »   

The U.S. government may end up throwing away unused doses of swine flu vaccine if people cannot get it soon… »   

GlaxoSmithKline has yet to get U.S. government approval for its swine flu vaccine, the company said on Tuesday, while Novartis… »